Zhao Xiaolan, Ren Zitong, Qi Junhai, Qi Enfeng, Zhao Xiaoyu, Li Guojun, Yu Ting
Research Center for Mathematics and Interdisciplinary Sciences, Frontiers Science Center for Nonlinear Expectations (Ministry of Education), Shandong University, Qingdao, 266237, China.
School of Mathematics, Shandong University, Jinan, Shandong, 250100, China.
BMC Genomics. 2025 Jun 30;26(1):670. doi: 10.1186/s12864-025-11866-6.
Gene fusion is a prevalent occurrence in cancer patients, and fusions are significant both as diagnostic biomarkers and as therapeutic targets for cancer. Long-read transcriptome sequencing technology provides new opportunities for gene fusion detection. In this research, we have developed GFvoter, a novel method that employs a multivoting strategy to identify gene fusions from long-read transcriptome sequencing data. GFvoter calls two RNA-seq aligners, two fusion detection tools, and a newly designed scoring mechanism to conduct the so-called voting process in turn, which enables the accurate detection of potential fusions. We validated GFvoter using both simulated and real cell line datasets from PacBio and Nanopore and found that GFvoter significantly outperforms alternative methods. Moreover, GFvoter successfully reported the RPS6KB1:VMP1 gene fusion in the MCF-7 cell line, while none of the other tested tools detected this fusion. Overall, our findings show that GFvoter can accurately identify gene fusions from long-read RNA-seq data, which has the potential to improve cancer diagnosis and treatment. GFvoter is available at https://github.com/xiaolan-z/GFvoter .
基因融合在癌症患者中普遍存在,并且融合作为癌症的诊断生物标志物和治疗靶点都具有重要意义。长读长转录组测序技术为基因融合检测提供了新的机遇。在本研究中,我们开发了GFvoter,这是一种采用多轮投票策略从长读长转录组测序数据中识别基因融合的新方法。GFvoter依次调用两个RNA-seq比对器、两个融合检测工具以及一种新设计的评分机制来进行所谓的投票过程,从而能够准确检测潜在的融合。我们使用来自PacBio和Nanopore的模拟和真实细胞系数据集对GFvoter进行了验证,发现GFvoter显著优于其他方法。此外,GFvoter成功报告了MCF-7细胞系中的RPS6KB1:VMP1基因融合,而其他测试工具均未检测到这种融合。总体而言,我们的研究结果表明,GFvoter能够从长读长RNA-seq数据中准确识别基因融合,这有可能改善癌症的诊断和治疗。GFvoter可在https://github.com/xiaolan-z/GFvoter获取。